merestinib
merestinib: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: ELI LILLY & Co (LLY)
Development Pipeline (1)
| Company | Phase |
|---|---|
| ELI LILLY & Co (LLY) | Phase 2 |
Clinical Trials (1)
Randomized, Double-Blind, Phase 2 Study of Ramucirumab or Merestinib or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment in Patients With Advanced or Metastatic Biliary Tract Cancer
Frequently asked questions
Who is developing merestinib?
merestinib is being developed by ELI LILLY & Co.
How many clinical trials involve merestinib?
BioSniper tracks 1 clinical trial involving merestinib.
Analyze ELI LILLY & Co & merestinib with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company